Skip to content

The AMD Experts

teamphoto

Our Team

The MacuLogix team is committed to empowering primary eye care professionals with the technology and tools needed to create AMD Centers of Excellence®.

Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.

By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize is that what’s good for our patients winds up being good for our practices.

Jeffry D. Gerson, OD, FAAO Jeffry Gerson, OD, FAAO View all testimonials

Latest News & Upcoming Events

View More
Article: January 17, 2020 | Review of Optometry

AdaptDx Pro Simplifies Dark Adaptation Testing

If you want to help identify AMD patients sooner so that management can begin before substantial vision loss occurs, a new product from Maculogix aims to help.

Press Releases: January 14, 2020

MacuLogix Introduces the AdaptDx Pro Guided by Theia

MacuLogix, Inc. announces the next generation of dark adaptation functional testing with the introduction of the AdaptDx Pro guided by Theia.

Article: December 2019 | Modern Optometry

A New Dynamic in Health Care?

How at-home genetic testing has affected AMD patient encounters with eye care practitioners. By Dr. Damon Dierker, OD, FAAO and Dr. Scott Schachter, OD.

Put Our Expertise to Work

Testing with AdaptDx Pro

AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.

Implementation Expertise

Each AdaptDx Pro purchase is supported by our AMD Excellence Program™ to help you achieve your patient care and practice revenue goals.